Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(13%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph not_applicable
3
38%
Ph phase_2
1
13%
Ph phase_3
2
25%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
2(33.3%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)
Other(2)

Detailed Status

Completed4
unknown2
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (16.7%)
Phase 32 (33.3%)
N/A3 (50.0%)

Trials by Status

terminated113%
completed450%
unknown225%
recruiting113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
PROCEDURE
Total Trials
8